RedHill Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsRedHill Biopharma

RedHill Biopharma(RDHL)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aemcolo	Rifamycin	2018-11-16	2025	—
Talicia	Amoxicillin, Omeprazole, Rifabutin	2019-11-01	2026-2042	Urinary tract infections , Sinusitis , Otitis media , Bacterial infections , Bacterial skin diseases , Soft tissue infections , Chlamydia infections , Helicobacter infections , Duodenal ulcer , Streptococcal infections , Lyme disease , Listeriosis , Human bites , Actinomycosis , Staphylococcal infections , Haemophilus infections , Nontuberculous mycobacterium infections , Gastroesophageal reflux , Infectious skin diseases , Mycoplasma pneumonia , Bronchitis , Stomach ulcer , Tonsillitis , Zollinger-ellison syndrome , Esophagitis , Protozoan infections , Pulmonary tuberculosis , Mycobacterium avium-intracellulare infection , Heartburn , Mycobacterium infections

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

healthy volunteers/patients

,

bacterial infections

,

opioid-related disorders

,

,

renal insufficiency

,

,

,

pulmonary sarcoidosis

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

chlamydophila infections

,

chlamydial pneumonia

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

drug-related side effects and adverse reactions

,

staphylococcal infections

,

staphylococcus aureus

,

ventilator-associated pneumonia

,

mycobacterium infections

,

communicable diseases

,

helicobacter infections

,

,

,

,

nontuberculous mycobacterium infections

,

,

prosthesis-related infections

,

latent tuberculosis

,

bacterial pneumonia

,

acinetobacter infections

,

,

,

,

mycobacterium avium-intracellulare infection

,

acquired immunodeficiency syndrome

,

,

mycobacterium avium complex

,

pulmonary tuberculosis

,

,

,

paratuberculosis

,

multiple drug resistance

,

disease susceptibility

,

multidrug-resistant tuberculosis

,

drug interactions

,

aids-related opportunistic infections

,

aids-related complex

,

,

,

mycobacterium avium complex

,

,

mycobacterium avium-intracellulare infection

,

mycobacterium infections

,

,

paratuberculosis

,

,

Interferon beta

,

ulcerative colitis

,

merkel cell carcinoma

,

polyomavirus infections

,

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

peripheral arterial disease

,

venous thrombosis

,

atrial fibrillation

,

venous thromboembolism

,

,

pulmonary embolism

,

,

thromboembolism

,

,

coronary artery disease

pancreatic neoplasms

,

,

cholangiocarcinoma

,

,

coronavirus infections

,

multiple myeloma

,

plasma cell neoplasms

,

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

,

breast neoplasms

,

hematologic neoplasms

,

,

neoplasm metastasis

,

pleural empyema

,

,

myocardial infarction

,

st elevation myocardial infarction

,

,

,

postoperative complications

,

wounds and injuries

,

communicable diseases

,

,

musculoskeletal diseases

,

,

prosthesis-related infections

,

pathologic processes

urologic neoplasms

,

,

,

,

plasma cell neoplasms

,

,

,

respiratory tract diseases

,

pleural effusion

,

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

neoplasms by site

,

malignant pleural effusion

,

pleural diseases

,

pleural neoplasms

,

squamous cell carcinoma of head and neck

,

cutaneous malignant melanoma

,

,

stomach neoplasms

,

ovarian neoplasms

,

kidney transplantation

,

graft rejection

,

psychology rejection

,

male breast neoplasms

,

uveal neoplasms

,

,

hodgkin disease

,

pancreatic ductal carcinoma

,

serous cystadenocarcinoma

,

,

ovarian epithelial carcinoma

,

,

adenocarcinoma of lung

,

bronchiolo-alveolar adenocarcinoma

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

endometrial neoplasms

,

merkel cell carcinoma

,

head and neck neoplasms

,

triple negative breast neoplasms

,

,

type 2 diabetes mellitus

,

breast neoplasms

,

non-small-cell lung carcinoma

,

diabetes mellitus

,

,

rheumatoid arthritis

,

colorectal neoplasms

,

neoplasm metastasis

,

multiple myeloma

,

,

,

,

liver neoplasms

,

,

hepatocellular carcinoma

,

transitional cell carcinoma

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

myeloid leukemia chronic-phase

,

,

chronic hepatitis b

,

chronic hepatitis

,

,

,

juvenile arthritis

,

esophageal neoplasms

,

wasting syndrome

,

,

,

urinary bladder neoplasms

,

rectal neoplasms

,

cardiovascular diseases

,

lymphoid leukemia

,

acute coronary syndrome

,

,

atrial fibrillation

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia accelerated phase

,

lupus nephritis

,

systemic lupus erythematosus

,

giant cell arteritis

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

,

,

colonic neoplasms

,

,

,

brain neoplasms

,

,

bipolar disorder

,

sjogren's syndrome

,

prostatic neoplasms

,

hematologic neoplasms

,

primary myelofibrosis

breast neoplasms

,

pancreatic neoplasms

,

,

irritable bowel syndrome

,

,

,

,

,

gastroenteritis

Hidroxicloroquina

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use